The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis
Abstract
Several lines of evidence have suggested that oxidative stress plays an important role for the pathogenesis of nonalcoholic steatohepatitis (NASH). Therefore, by using immunohistochemical staining of liver biopsy samples, we measured hepatic 7,8-dihydro-8-oxo-2′ deoxyguanosine (8-oxodG), a DNA base-modified product generated by hydroxyl radicals, of 38 NASH patients and compared with 24 simple steatosis and 10 healthy subjects. Relation of hepatic 8-oxodG with clinical, biochemical, and histologic variables and changes after iron reduction therapy (phlebotomy plus iron–restricted diet) were also examined. Hepatic 8-oxodG levels were significantly higher in NASH compared with simple steatosis (17.5 versus 2.0 8-oxodG–positive cells/105 μm2; P < 0.0001). 8-oxodG was significantly related to iron overload condition, glucose-insulin metabolic abnormality, and severities of hepatic steatosis in NASH patients. Logistic regression analysis also showed that hepatic iron deposit and insulin resistance were independent variables associated with elevated hepatic 8-oxodG. After the iron reduction therapy, hepatic 8-oxodG levels were significantly decreased (from 20.7 to 13.8 positive cells/105 μm2; P < 0.01) with concomitant reductions of serum transaminase levels in NASH patients. In conclusion, iron overload may play an important role in the pathogenesis of NASH by generating oxidative DNA damage and iron reduction therapy may reduce hepatocellular carcinoma incidence in patients with NASH. (Cancer Epidemiol Biomarkers Prev 2009;18(2):424–32)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These authors also reported that in steatosis, saturation of the -oxidation pathway with excess free fatty acids leads to further generation of H 2 O 2 , and other ROS.”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Fujita et al.,(2009)
In the citing paper
“Circulating prohepcidin was reported to be associated with parameters of glucose and iron metabolism, in subjects with altered glucose tolerance (Fujita et al., 2009).”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Fujita et al., 2009
In the citing paper
“Further, Fujita et al.,(2009) reported that NASH patients had elevated levels of hepatic 8-oxodG which is is a DNA base-modified product generated by hydroxyl radicals.The level of this product was reduced by iron reduction therapy.”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Fujita et al.,(2009)
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG
Shibutani, S., Takeshita, M., & Grollman, A. P. (1991) · Nature · doi:10.1038/349431a0 · Cited by 2,224
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., CARUCCI, P., Musso, A., Paolis, P. D., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,436
Kasai, H. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00035-5 · Cited by 1,157
R�sen, P., Nawroth, P., King, G. L., M�ller, W., Tritschler, H., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 890
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 653
Research works printed but not linked: 1
- Japanese Society for the Study of Obesity. New criteria of obesity [in Japanese]. J Jpn Soc Obes 2000;6:18–28.
Cited by
Sorted by citations
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Chen, Z., Tian, R., She, Z., Cai, J., & Li, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.025 · Cited by 1,340
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Molecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 664
Pathogenesis of Nonalcoholic Steatohepatitis
Machado, M. V., & Diehl, A. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.066 · Cited by 550
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Spahis, S., DELVIN, E. E., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6776 · Cited by 394
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Dongiovanni, P., Fracanzani, A. L., Fargion, S. R., & Valenti, L. V. C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.008 · Cited by 364
Watanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1050-7 · Cited by 328
Self-citationInvolvement of free radicals and oxidative stress in NAFLD/NASH
Sumida, Y., Niki, E., Naito, Y., & Yoshikawa, T. (2013) · Free Radical Research · doi:10.3109/10715762.2013.837577 · Cited by 280
Iron and liver fibrosis: Mechanistic and clinical aspects
Mehta, K. J., Farnaud, S., & Sharp, P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i5.521 · Cited by 280
Watanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12511 · Cited by 197
Self-citationLinhart, K. B., Bartsch, H., & Seitz, H. K. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.009 · Cited by 183
Ore, A., & Akinloye, O. A. (2019) · Medicina · doi:10.3390/medicina55020026 · Cited by 192
Review article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Rives, C., Fougerat, A., Ellero‐Simatos, S., Loiseau, N., Guillou, H., Gamet‐Payrastre, L., & Wahli, W. (2020) · Biomolecules · doi:10.3390/biom10121702 · Cited by 167
Iron and non-alcoholic fatty liver disease
Britton, L., Subramaniam, V., & Crawford, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8112 · Cited by 136
Ucar, F., Sezer, S., Erdogan, S., Akyol, S., Armutcu, F., & Akyol, O. (2013) · Redox Report · doi:10.1179/1351000213y.0000000050 · Cited by 143
Mouzaki, M., & Allard, J. P. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824cf51e · Cited by 125
Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?
Hashimoto, E., & Tokushige, K. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00872.x · Cited by 120
Iron Metabolism in Nonalcoholic Fatty Liver Disease
Nelson, J. E., Klintworth, H. M., & Kowdley, K. V. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0234-4 · Cited by 119
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
Doulberis, M., Kotronis, G., Gialamprinou, D., Kountouras, J., & Katsinelos, P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.013 · Cited by 117
Li, L.-X., Guo, F., Liu, H., & Zeng, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04239-9 · Cited by 113
Tanaka, S., Miyanishi, K., Kobune, M., Kawano, Y., Hoki, T., Kubo, T., Hayashi, T., Sato, T., Sato, Y., Takimoto, R., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0739-0 · Cited by 110
Kim, Y. W., Lee, S. M., Shin, S. M., Hwang, S. J., Brooks, J. S., Kang, H. E., Lee, M. G., Kim, S. C., & Kim, S. G. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.018 · Cited by 106
Dysmetabolic iron overload syndrome (DIOS)
Deugnier, Y., Bardou‐Jacquet, E., & Lainé, F. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.05.036 · Cited by 107
Fargion, S. R., Valenti, L. V. C., & Fracanzani, A. L. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.07.006 · Cited by 89
The metabolic basis of nonalcoholic steatohepatitis
Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 93
Silva, H. E. D., Arendt, B. M., Noureldin, S. A., Therapondos, G., Guindi, M. M., & Allard, J. P. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.01.009 · Cited by 86
Sebaï, H., Sani, M., Yacoubi, M. T., Aouani, E., Ghanem‐Boughanmi, N., & Ben‐Attia, M. (2010) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2009.12.031 · Cited by 81
Hagström, H., Nasr, P., Bottai, M., Ekstedt, M., Kechagias, S., Hultcrantz, R. W., & Stal, P. I. (2016) · Liver International · doi:10.1111/liv.13144 · Cited by 79
Eguchi, Y., Mizuta, T., Sumida, Y., Ishibashi, E., Kitajima, Y., Isoda, H., Horie, H., Tashiro, T., Iwamoto, E., Takahashi, K., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0340-3 · Cited by 76
Ashla, A. A., Hoshikawa, Y., Tsuchiya, H., Hashiguchi, K., Enjoji, M., Nakamuta, M., Taketomi, A., Maehara, Y., Shomori, K., Kurimasa, A., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00646.x · Cited by 73
Ning, K., Lu, K., Chen, Q., Guo, Z., Du, X., Riaz, F., Feng, L., Fu, Y., Yin, C., Zhang, F., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01689 · Cited by 70
Hoki, T., Miyanishi, K., Tanaka, S., Takada, K., Kawano, Y., Sakurada, A., Sato, M., Kubo, T., Sato, T., Sato, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27774 · Cited by 70
Interaction between hepatitis C virus and metabolic factors
Kawaguchi, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i11.2888 · Cited by 69
Wei, Y., Zhao, M., Yang, F., Mao, Y., Xie, H., & Zhou, Q. (2016) · Scientific Reports · doi:10.1038/srep29110 · Cited by 65
The Effect of Multispecies Probiotic Supplementation on Iron Status in Rats
Skrypnik, K., Bogdański, P., SCHMIDT, M. T., & Suliburska, J. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-1658-1 · Cited by 62
The role of iron in hepatic inflammation and hepatocellular carcinoma
Miyanishi, K., Tanaka, S., Sakamoto, H., & Kato, J. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.006 · Cited by 58
Kawaguchi, T. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i16.1943 · Cited by 55
Kaji, K., Yoshiji, H., Kitade, M., Ikenaka, Y., Noguchi, R., Shirai, Y., Aihara, Y., Namisaki, T., Yoshii, J., Yanase, K., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2010 · Cited by 55
Tanaka, Y., Ikeda, T., Yamamoto, K., Ogawa, H., & Kamisako, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07180.x · Cited by 53
Uysal, S., Armutçu, F., Aydoğan, T., Akın, K., İkizek, M., & Yiǧitoǧlu, M. R. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.09.017 · Cited by 53
Iron overload in nonalcoholic steatohepatitis
Fujita, N., & Takei, Y. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-387042-1.00006-x · Cited by 49
Self-citationPocha, C., & Xie, C.-C. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.01 · Cited by 45
Non-alcoholic fatty liver disease: is iron relevant?
O’Brien, J., & Powell, L. W. (2011) · Hepatology International · doi:10.1007/s12072-011-9304-9 · Cited by 42
Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis
Simon, Y., Kessler, S. M., Gemperlein, K., Bohle, R. M., Müller, R., Haybaeck, J., & Kiemer, A. K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17839 · Cited by 41
Aguiar, O., Gollücke, A. P. B., de Moraes, B. B., Pasquini, G., Catharino, R. R., Riccio, M. F., Ihara, S. S. M., & Ribeiro, D. A. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510004368 · Cited by 41
Zimmermann, A., Zimmermann, T., Schattenberg, J. M., Pöttgen, S., Lotz, J., Rossmann, H., Roeddiger, R., Biesterfeld, S., Geiss, H. C., Schuchmann, M., et al. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.01.011 · Cited by 38
Atarashi, M., Izawa, T., Miyagi, R., Ohji, S., Hashimoto, A., Kuwamura, M., & Yamate, J. (2018) · Nutrients · doi:10.3390/nu10020175 · Cited by 38
Fisher, A. L., Srole, D. N., Palaskas, N. J., Meriwether, D., Reddy, S. T., Ganz, T., & Nemeth, E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101156 · Cited by 37
Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation?
Moris, W., Verhaegh, P. L. M., Jonkers, D. M. A. E., van Deursen, C. T. B. M., & Koek, G. H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1693114 · Cited by 33
DNA damage response and sphingolipid signaling in liver diseases
Nagahashi, M., Matsuda, Y., Moro, K., Tsuchida, J., Soma, D., Hirose, Y., Kobayashi, T., Kosugi, S., Takabe, K., Komatsu, M., et al. (2015) · Surgery Today · doi:10.1007/s00595-015-1270-8 · Cited by 34
Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC
Liu, K., & McCaughan, G. W. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_2 · Cited by 33
Gagné, J. W., Wakshlag, J. J., Rutzke, M. A., & Glahn, R. P. (2013) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.243.5.658 · Cited by 32
Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis
Houben, T., Brandsma, E. T., Walenbergh, S. M. A., Hofker, M. H., & Shiri‐Sverdlov, R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.008 · Cited by 32
McCarty, M. F. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.029 · Cited by 30
Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?
Ogłuszka, M., Lipiński, P., & Starzyński, R. R. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1862047 · Cited by 28
Rescuing hepatocytes from iron-catalyzed oxidative stress using vitamins B1 and B6
Mehta, R., Dedina, L., & O'Brien, P. J. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.03.015 · Cited by 28
Thomas, A., Klein, M. S., Stevens, A. P., Reinders, Y., Hellerbrand, C., Dettmer, K., Gronwald, W., Oefner, P. J., & Reinders, J. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2012.12.027 · Cited by 27
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target
Chen, H. (2022) · Liver Research · doi:10.1016/j.livres.2022.09.003 · Cited by 24
Thomas, A., Stevens, A. P., Klein, M. S., Hellerbrand, C., Dettmer, K., Gronwald, W., Oefner, P. J., & Reinders, J. (2012) · PROTEOMICS · doi:10.1002/pmic.201100628 · Cited by 24
Serum Markers of Iron Metabolism in Chronic Liver Diseases
Penkova, M., Andonova, A., Milcheva, H., Ivanova, N. G., Kyuchukova, S., Nikolova, M., & Platikanova, M. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.251 · Cited by 22
Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy
Miyanishi, K. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.593 · Cited by 22
Hyperferritinemia in patients with nonalcoholic fatty liver disease
Barros, R. A., Cotrim, H. P., Daltro, C., & Oliveira, Y. A. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.03.284 · Cited by 20
Iron, Oxidative Stress and Health
Udipi, S., Ghugre, P., & Gokhale, C. (2012) · Oxidative Stress - Molecular Mechanisms and Biological Effects · doi:10.5772/34975 · Cited by 17
“Circulating prohepcidin was reported to be associated with parameters of glucose and iron metabolism, in subjects with altered glucose tolerance (Fujita et al., 2009).”
BackgroundLiu, Y., Qin, X., Chen, T., Chen, M., Wu, L., & He, B. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1344924 · Cited by 18
Pathogenesis of Nonalcoholic Fatty Liver Disease
Machado, M. V., & Diehl, A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00025-2 · Cited by 17
Serum hepcidin levels in chronic liver disease: a systematic review and meta-analysis
Sharma, R., Zhao, W., Zafar, Y., Murali, A. R., & Brown, K. E. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0540 · Cited by 16
Khabour, O. F., Soudah, O., & Ayesh, M. H. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.09.006 · Cited by 15
Lobbes, H., Gladine, C., Mazur, A., Pereira, B., Dualé, C., Cardot, J., & Ruivard, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.012 · Cited by 14
Nonalcoholic fatty liver disease-related cardiovascular risk
Tanoğlu, A., & Kara, M. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000434 · Cited by 13
Post-Liver Transplant Metabolic Syndrome
Choudhury, A. K., Singh, S. P., Deshmukh, A., Sahoo, B., & Eslam, M. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.101368 · Cited by 10
Teufel, U., Peccerella, T., Engelmann, G., Bruckner, T. M., Flechtenmacher, C., Millonig, G., Stickel, F., Hoffmann, G. F., Schirmacher, P., Mueller, S., et al. (2015) · PubMed Central · doi:10.5167/uzh-119314 · Cited by 9
Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism
Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 12
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Sohal, A., Chaudhry, H., & Kowdley, K. V. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.006 · Cited by 9
Raju, G. J. N., Sarita, P., & Murthy, K. S. R. (2017) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2017.01.060 · Cited by 7
Sukerkar, P. A., Rezvi, U. G., MacRenaris, K. W., Patel, P. C., Wood, J. C., & Meade, T. J. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22627 · Cited by 6
Ferroptosis as a molecular target of epigallocatechin gallate in diseases
Wang, L., Tang, C., Zhang, Q., & Pan, Q. (2024) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2024.2401892 · Cited by 5
Uchino, K., Tateishi, R., Nakagomi, R., Fujiwara, N., Minami, T., Sato, M., Enooku, K., Nakagawa, H., Asaoka, Y., Kondo, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200943 · Cited by 5
Yeom, M. Y., Kim, Y. J., Chung, N. G., Lee, J. W., Jang, P., Cho, B., Kye, C. S., & Jeong, D. C. (2015) · Blood Research · doi:10.5045/br.2015.50.3.140 · Cited by 5
de Moraes, B. B., Pasquini, G., Aguiar, O., Gollücke, A. P. B., Ihara, S. S. M., Tenório, N. M., Andersen, M. L., Catharino, R. R., Spadari-Bratfisch, R. C., & Ribeiro, D. A. (2011) · Hepatology International · doi:10.1007/s12072-011-9275-x · Cited by 4
Hemochromatosis, alcoholism and unhealthy dietary fat: a case report
Venkatachalam, S., Adeseye, A., Billy, B., & Kalliny, M. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02610-7 · Cited by 4
Erythropoietin hyporesponsiveness in non‐alcoholic fatty liver disease
Zou, H., Wong, R. S. M., & Yan, X. (2024) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13869 · Cited by 3
Free Radicals and Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Sumida, Y., Naito, Y., & Yoshikawa, T. (2010) · Frontiers of gastrointestinal research · doi:10.1159/000319983 · Cited by 3
Hazhirkarzar, B., Wu, Q., Tang, H., Baghdadi, A., Motaghi, M., Habibabadi, R. R., Shaghaghi, M., Ghadimi, M., Borhani, A., Mohseni, A., et al. (2023) · Clinical Imaging · doi:10.1016/j.clinimag.2023.05.003 · Cited by 3
Mahmood, A. A., Zhang, J., Liao, R., Pan, X., Xu, D., Xu, H., & Zhou, Q. (2019) · RSC Advances · doi:10.1039/c9ra02430a · Cited by 3
[The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
Kwon, O., Kim, J., & Kim, J. H. (2017) · The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · doi:10.4166/kjg.2017.69.6.348 · Cited by 3
Safety and efficacy of dietary freshwater clam (Corbicula fluminea) extract in clinical research
Shimazoe, T., Kobayashi, D., Kawashiri, T., Chijimatsu, T., Umeki, M., & Mochizuki, S. (2022) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v12i6.928 · Cited by 2
Exocycilic DNA Adducts in a Murine Model of Non-alcoholic Steatohepatitis
Peluso, M. E. M. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s3-003 · Cited by 2
Regulation of Iron Metabolism in NAFLD/NASH
Hamada, Y., & Hirano, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107221 · Cited by 1
Crawford, D. H., Fletcher, L. M., & Kowdley, K. V. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_22 · Cited by 1
Iron, Oxidative Stress, and Cancer
Sung, M., & Bae, Y. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405205-5.00013-1 · Cited by 1
Santrampurwala, N. (2016) · The University of Queensland · doi:10.14264/uql.2016.365 · Cited by 1
Evangelista, A. S. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-01082013-134115
Kara, M., Erdal, M., Hastanesi, E. A., Asker, E., Aile, H., & Kelimeler, A. (2014)
EVALUATION OF SERUM-FREE IRON AND GLYCATED HEMOGLOBIN IN UNCONTROLLED TYPE-II DIABETIC PATIENTS
Kamalam, R., Ganesan, N., & ANBAZHAGAN, M. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i1.15330
宋, 清. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.99165
Metadata
- Authors
- Fujita, N., Miyachi, H., Tanaka, H., Takeo, M., Nakagawa, N., Kobayashi, Y., Iwasa, M., Watanabe, S., & Takei, Y.
- Affiliations
- Mie University (JP)
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2009-02-01
- Volume
- 18
- Issue
- 2
- Pages
- 424-432
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2164144565
- Cited by
- 107
- References
- 40
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 8 · 2018: 8 · 2017: 5 · 2016: 10 · 2015: 9 · 2014: 7 · 2013: 7 · 2012: 6
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, iron overload, oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, oxidative stress, phlebotomy, insulin resistance, hepatic steatosis, hepatocellular carcinoma risk, hydroxyl radicals
- MeSH terms
- 8-Hydroxy-2'-Deoxyguanosine, Adult, Aged, Analysis of Variance, Deoxyguanosine, DNA Damage, Fatty Liver, Female, Carcinoma, Hepatocellular, Humans, Insulin Resistance, Liver Function Tests, Liver Neoplasms, Male, Middle Aged, Severity of Illness Index, Logistic Models, Case-Control Studies, Oxidative Stress, Statistics, Nonparametric, Iron Overload
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
